H.C. Wainwright initiated coverage on Adverum Biotech with a new price target
$ADVM
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
H.C. Wainwright initiated coverage of Adverum Biotech with a rating of Buy and set a new price target of $30.00